Linda Evans O’Connor, M.B.A. Promoted to Head of Business Processes and Regulatory at Lachman Consultant Services, Inc.

We are pleased to announce that Linda Evans O’Connor, M.B.A. has been promoted to Head of Business Processes and Regulatory at Lachman Consultant Services, Inc. Ms. Evans O’Connor will continue in her recognized leadership role as part of the Compliance Practice and will oversee the administrative activities of the Regulatory Department as well as support the on-going development of the Lachman brand and marketing strategy. In her new combined role, she will serve as principal interface in key matters and provide oversight in developing program management across all areas including existing, new, and evolving projects.

Academically, Linda earned her M.B.A. in Marketing from Rutgers University and she was awarded a B.S. degree in Biochemistry and Toxicology, from Carnegie-Mellon University. Linda served in Senior Management roles in Quality, Compliance and Regulatory Affairs prior to joining Lachman Consultants.

On behalf of Lachman Consultants, we congratulate Linda and wish her continued success at Lachman Consultants.

For more than 30 years, Lachman Consultants has been the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries. With its strong and extensive cadre of consultant specialists and an unparalleled management team, its Compliance, Science & Technology, and Regulatory Practices provide the most expert counsel and array of services available. Lachman Consultants is proud of its tradition of supporting industry efforts to develop and ensure safe, effective and high-quality medical products. It remains committed to helping the industry anticipate and address its challenges through the development and implementation of practical, sustainable and cost-effective solutions based on the integration of scientific principles, evolving regulatory expectations, and technology.